BRIEF-Genmab gets European conditional marketing authorization for Darzalex
May 23, 2016 at 06:56 AM EDT
* Says the European Commission (EC) has granted a conditional marketing authorization for first-in-class CD38 antibody Darzalex (daratumumab) for multiple Myeloma
